Name (Synonyms) | Correlation | |
---|---|---|
drug2480 | SARILUMAB Wiki | 1.00 |
drug3408 | placebo Wiki | 0.27 |
Name (Synonyms) | Correlation | |
---|---|---|
D045169 | Severe Acute Respiratory Syndrome NIH | 0.05 |
D018352 | Coronavirus Infections NIH | 0.04 |
Name (Synonyms) | Correlation |
---|
There is one clinical trial.
Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus. At this time, there are no specific vaccines or treatments for COVID-19. However, there are many ongoing clinical trials evaluating potential treatments Drugs used to treat malaria infection has shown to be beneficial for many other diseases, including viral infections. In this Clinical trial, Investigators will evaluate the effect of Artemisinin / Artesunate on morbidity of COVID-19 patients in decreasing the course of the disease and viral load in symptomatic stable positive swab COVID-19 patients. Investigators are hypothesizing that due to the antiviral properties of this drug it will help as a treatment for the COVID -19 patients. In improving their condition and clearing the virus load,
Description: absence of the virus shedding evidenced by negative swabs
Measure: length of stay in hospital Time: within the first 6 days interventionDescription: reduction of morbidity and mortality
Measure: number of ICU admission Time: 14 daysDescription: finding the time that the symptoms disappear
Measure: resolution of symptoms Time: 6 days - 10 day